BSD SCIENCE
Oral Drug Delivery System for Controlled Release (CR) of Lipophilic Drugs
StartupBSD SCIENCE is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2022. Oral Drug Delivery System for Controlled Release (CR) of Lipophilic Drugs. BSD SCIENCE was founded by Yochai Yakovson. The company has 1-10 employees.
The company follows a B2B business model. Product stage: R&D.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQTel Aviv-Yafo
- DistrictCenter District
- Last RoundUndisclosed
Yochai YakovsonFounder & CEO
What does BSD SCIENCE do?
BSD SCIENCE is a biotech company that has developed a unique oral dosage form designed for controlled release (CR) of lipophilic drugs, in order to achieve long duration of effect, less adverse effects and higher compliance to treatment. The platform is suitable for lipophilic molecules used in the Medical Cannabis, Pharma industry and Dietary Supplement markets. During 2022, the company completed a POC PK animals study, where promising results were achieved, and U.S. Provisional Patent Application was submitted. BSD SCIENCE plans to move on towards human PK study.
Who founded BSD SCIENCE?
BSD SCIENCE was founded in 2022 by Yochai Yakovson (Founder & CEO).
What sector is BSD SCIENCE in?
BSD SCIENCE operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is BSD SCIENCE located?
BSD SCIENCE is based in Tel Aviv-Yafo, Israel, Center District.